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The propagation of mouse mammary tumor virus 
(MMTV) has been analyzed in mice defective for expm 
sion of CD40 ligand (CD4OL). Mice with endogenous 
viral superantigen (SAG) delete T cells with cognate 
Vf3 independent of CD4OL expression. Nevertheless, 
CD40L- mice do not show deletion of cognate T cells 
after being exposed to Infectious MMTV and have 
greatly diminished viral replication. The response of 
CD4OL- T cells to SAG In vitro Is also Impaired, but 
can be reconstituted by adding B cells activated by 
recombinant CD40L to express costimulatory mole- 
cules. Thus, direct CD40L-dependent B cell activation 
appears to be a critical step In the life cycle of MMTV. 
The initial step in SAG-dependent T cell activation, and 
hence the MMTV life cycle, may be mediated by non-B 
cells, because splenocytes from B cell-deficient SAG- 
transgenlc mice are able to activate cognate T cells. 
Introduction 
The role of the immune system is to limit the spread of 
infectious agents by mounting a specific and appropriate 
response against them. This is an efficient strategy, but 
it is open to subversion. One example of this is the ability 
of mouse mammary tumor viruses (MMTV) to stimulate 
a vigorous T cell response by expressing superantigens 
(vSAG) encoded in an open reading frame in the 3’ long 
terminal repeat (LTR) (orf or sag), which stimulate T cells 
with certain cognate VP gene segments expressed on their 
T cell receptors (TCR). It is thought that this vigorous T 
ceil response stimulates B cells, which initially integrate 
the virus, and this in turn leads to viral propagation, B cell 
migration to the mammary gland, and transmission of the 
virus in milk. 
The various components of this scenario have all been 
tested in earlier experiments. Thus, MMTV cannot be 
propagated in neonatally thymectomized (Squartini et al., 
1970) or nude mice (Tsubura et al., 1966) which lack a 
thymus and T cells and therefore do not make a T cell 
response to the virus. The involvement of the sag gene 
in the process was shown by passaging MMTV through 
mice made transgenic for the same sag (Golovkina et al, 
1992) or naturally expressing the same endogenous Mtv 
(Held et al., 1993a). Finally, the role of B cells in the pro- 
cess has been implicated by mice lacking B cells, which 
cannot transmit the virus to their progeny (Beutner et al., 
1994), and footpad injection of virus (Held et al., 1993b, 
1994b) or ingestion via the gut (Karapetian et al., 1994) 
leads to a vigorous T-B interaction that is believed to prop- 
agate the virus. 
Nevertheless, little is known of the mechanism by which 
this putative T-B interaction takes place. A likely mecha- 
nism, based on studies of other T-B interactions, is that 
stimulation of T cells leads to expression of CD40 ligand 
(CD40L) (Armitage et al., 1992; Noelle et al., 1992) on the 
T cell surface, and this then engages CD40 on the B cell 
with which the T cell is in contact. In this paper, we use 
a newly derived strain of mice lacking expression of CD4OL 
(Xu et al., 1994) to demonstrate the involvement of this 
molecule in the propagation of MMTV infection. 
Results 
CD40L Knockout Mice as a Model System for 
Studying Cognate T-B lnteractlon 
To investigate the role of CD4OL in cognate T-B interac- 
tion, we turned to a newly produced strain of mice that 
lack CD40L due to homologous recombination in embry- 
onic stem cells and transmission in the germ line (Xu et 
al., 1994). This system is particularly favorable, since the 
gene for CD40L is on the X chromosome, so heterozygous 
males are defective in CD40L expression, while heterozy- 
gous females are normal. In order for us to use such mice 
to study MMTV propagation, we had to first document 
that induction of deletion or functional tolerance occurred 
normally in CD40L knockout mice. 
CD40L Knockout Mice Show Normal Deletion 
Caused by MMTV (C3H) SAG 
CD40L- female mice on a C57BU6J (86) genetic back- 
ground were bred to C3H/HeN, H-2k mice, which were 
themselves transgenic for a complete hybrid provirus 
(HYB-PRO) (Golovkina et al., 1994). The gag and pal 
genes in HYB-PRO are derived from Mtvl, while the env 
and sag genes originated from exogenous MMTV C3H 
virus (Shackleford and Varmus, 1966). MMTV(C3H) SAG 
causes stimulation and deletion of Vf314- and VP15 
bearing T cells (Marrack et al., 1991; Choi et al., 1991). In 
the Fl hybrid generation, all males were CD40L deficient, 
expressed H-2k (l-E+), which is a necessary condition for 
observing deletion by MMTV SAG (Acha-Crbea et al., 
1991), and were either MMTV transgene negative or pOSi- 
tive. Females in this generation were also MMTV transgene 
negative or positive, but all expressed CD40L. Table 1 
demonstrates that the absence of CD40L did not prevent 
deletion of V614-bearing cells. The deletion was Vj314- 
specific, since Vf%-bearing cells were present in equal 
numbers in all groups. Thus, Tcells do not need to express 
CD40L to be deleted by endogenous SAG. 
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Table 1. CD4OL-Deficient Mice Are Able to Delete 
SAG-Reactive T Cells 
Percent of CD4 T Cells 
VP Male HYB-PRO- Male HYB-PRO+ Female HYB-PRO+ 
6 9.7 (10.6; 6.6) 11.7 f 0.3 11.3 f 0.7 
14 ll.O(i1.3; 10.6) 0.9 f 0.3 0.6 f 0.1 
PBL from male (CD40L-) and female (CD40L+) mice expressing MMTV 
C3H SAG (HYB-PRO+)or not (HYB-PRO-) were stained with anti-CD4 
and anti-V5 antibodies. 
Percent of CD4 cells expressing Vj36 or V614 (mean f SEM) are 
shown for groups of 2-4 animals. 
If two animals were used, both values are shown. 
CD40L Knockout Mice Are Susceptible to Tolerance 
The fact that CD40L-deficient mice are tolerized by ei- 
to an Endogenous Nominal Antigen 
Although the data in Table 1 show that SAG can induce 
tolerance in CD4OL knockout mice, we wanted to know 
whether other forms of tolerance are impaired. Therefore, 
we took advantage of the fact that H-2bXk mice are function- 
ally tolerant to the peptide Ea52-68 bound to I-Ab. We 
immunized normal or CD40L knockout H-2b mice as well 
as H-2bxk mice that were normal or defective in CD40L 
expression with Ea52-68 in complete Freund’s adjuvant 
(CFA) and measured the proliferative response of their 
lymph node T cells to Ea52-68. Figure 1 shows that all 
mice responded according to the presence or absence of 
the peptide, and not according to whether they expressed 
CD40L. Although the anti-peptide response in CD40L 
knockout mice was lower than in normal counterparts, one 
can easily see the difference in reactivity between H-2b 
versus H-2bxk. In contrast, reactivity to tuberculin, stimu- 
lated by CFA injection, was similar in all animals (Figures 
lC, 1D). These data strongly support the idea that tol- 
erance is dependent on antigen and not on CD40L ex- 
pression. 
T Figure 1. Hyporeactivity to Self-Peptide (Ea 
----I P 52-66) Is Preserved in CD46L Knockout Mice 
Proliferation of regional lymph node cells on 
- b%YO day 6 after footpad injection of Ea peptide in 
- Mix0 CFA and restimulation with peptide (A and B) 
ther endogenous superantigen or antigen makes it possi- 
ble to use deletion of Vj314-bearing T ceils as a readout 
in experiments in which we analyzed the role of T-B inter- 
actions on the propagation of MMTV infection in vivo. 
Mice Lacking B Ceils Due to Gene Knockout Can 
Also Delete and Activate T Ceils 
with Cognate VP Receptors 
B cells have been implicated in the propagation of MMTV 
in infected animals, yet T cells with cognate Vg are never- 
theless deleted in B cell-deficient mice (Beutner et al., 
1994). This implies that there must be non-B cell(s) that 
can participate in T cell recognition of SAG. To test this, 
we bred uMT mice, which have adeletion in the transmem- 
brane region of Cu and thus fail to form B cells (Kitamura 
et al., 1991) to two MMTV transgenic strains of mice. One, 
the HYB-PRO strain, deleted centrally and was almost 
devoid of single-positive Vj314bearing T ceils in both the 
thymus and the periphery (deletion of about 90%). In the 
second, the MMTV-ORF19 strain, the transgene con- 
sisted of two MMTV C3H LTRs (Golovkina et al, 1992), 
so that the only RNA it expressed was SAG. Low levels 
of expression from this transgene led to limited deletion 
of CD4+ T cells in the periphery (36% & 1.6%) only. No 
deletion was observed in the CD4+ single-positive thymo- 
cytes (-3.6% f 3.2%). No other forms of tolerance could 
be detected in the thymus: Vj314 cells reacted normally 
to stimulation with anti-V5 monocional antibody(MAb)(Go- 
lovkina et al., 1992). 
We also asked whether spleen cells from uMT mice 
Thus, if the results of the cross of uMT mice to these 
transgenic mice was deletion of Vj314bearing cells, it 
would mean that cells other that B cells can drive these 
two distinct types of deletion. Table 2 summarizes the data 
and shows that B cells are not necessary to observe either 
the high levels of deletion seen with HYB-PRO or the 
limited peripheral deletion seen with MMTV-ORF19 in the 
peripheral tissues. 
I . or tuberculin (C and D) is shown for normal (A, T C) or knockout (B, 0) mice expressing either 
H-2b or H-20b MHC. Data from indtidual ani- 
IO mals from a representative experiment shown 
pptlde eoncmcr.tkm. YM as stimulation index (ratio of experimental to 
background proliferatiin for each measure- 
ment) f SEM. KO, knockout; N, normal. 
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Table 2. VP14 T Cells Are Deleted in MMTV Transgenic B 
Cell-Deficient Mice 
Transgene 
Percent of Peripheral VP14 CD4+ T Cells’ 
B Cells Absent B Cells Present 
None 10.7 f 0.3 9.5 [9.1; 9.91 
HYB-PRO 0.9 f 0.25 (91.2) 0.7 f 0.1 (92.4) 
MMTV ORF19 6.9 f 0.3 (35.2) 6.0 I5.7; 6.31 (36.6) 
Mean f SEM. Data from 2-4 animals per group. If two animals were 
used per group, both values are shown. Deletion (percent), shown in 
parentheses, was calculated according to the formula: (a - b)/a x 
100%. where ‘a” and ‘b” was the percent of Vp14+CD4+T cells in non- 
transgenic and transgenic animals, respectively. 
could stimulate T cell responses. In Figure 2A, we used 
a VplB-bearing hybridoma to show that it could produce 
interleukin-2 (IL-2) when stimulated with sufficient num- 
bers of pMT cells, although it is clear that the mice with 
6 cells stimulate these same cells at least lOO-fold more 
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Figure 2. T Cells May Be Activated by Splenocytes from B Cell-Defi- 
cient Animals 
Spleen cells from B cell-deficient animals, expressing MMTV (C3H) 
sag as transgene were used to stimulate (A) activation of IL-2 produc- 
tion by Vblbbearing T cell hybridoma Kox15.6.3 (measured by 
[3H]thymidine incorporation into the CTLL IL-2dependent cell line) or 
(B) proliferation of primary T cells (measured by 13H]thymidine uptake 
by responding cells) from B cell-sufficient, H-2”’ mouse. tg, HYB- 
PRO; non-tg, nontransgenic litter mate. B+ and B-, mice with and with- 
out B cells, respectively. Data from representative experiments. 
strongly. As shown in Figure 28, HYB-PRO cells from 
pMT mice could also stimulate weak but significant re- 
sponses from MHC-matched naive responder T cells. 
Thus, non-B cells can drive deletion normally and are po- 
tential (though much weaker) stimulators of T cell re- 
sponses. 
CD40L Knockout Mice Fail to Delete Their 
VplCBearing T Cells When Exposed 
to MMTV C3H 
To ask whether CD40L was necessary for deletion to occur 
upon infection with MMTV, two groups of mice (CD40L-‘- 
x BlO.BR) Fl were fostered upon infected C3HIHeN or 
uninfected control mice. It can be seen in Figure 3A that 
male mice, which lack CD4OL, do not delete, while most 
female mice, which have the ligand, do show deletion (Fig- 
ure 38). Moreover, deletion is specific, as it affects VP14 
but not VP6 (see Figure 3, legend). Deletion of VB14+ T 
cells in male mice did not occur later in life; at the age of 
16-20 weeks, their peripheral blood cells (PBL) contained 
6.5% -+ 0.7%,whileCD40L+micehadonly4.3% f 0.3% 
of VP1 4+ CD4 cells. Notably, some of the CD40L+‘- females 
(2 of 8 in the experiment shown in Figure 3B) have shown 
no deletion of cognate T cells. Since CD40L has been 
shown to be variably expressed in human female carriers 
of a mutant gene due to random inactivation of X chromo- 
some (Hallenbaugh et al., 1994), the most likely explana- 
tion for our observation is variability of the numbers of 
CD40L+ Vp14+ T cells available for interaction with V-SAG 
at the initial stage of infection. We never observed a failure 
of deletion in CD40L+ malesorCD40L+“females. In subse- 
quent experiments, we crossed MMTV- Fl mice and fos- 
tered them on MMTV’ milk. This way, we generated males 
with and without CD40L and with H-2bxk or H-2k back- 
grounds, which was important because deletion occurs 
more extensively in H-2” C3H mice (data not shown), sug- 
gesting that amount of MHC class II (I-E) expressed is 
critical for the propagation of infection. Table 3 summa- 
rizes staining data obtained from these males. Deletion 
correlates with expression of CD40L. This shows that inac- 
tivation of CD40L protects Vj3 14 T cells from deletion, even 
though deletion itself is stronger in the H-2k homozygous 
background. Thus, it is clear that MMTV is either not repli- 
cating in the absence of CD40L or it does not cause dele- 
tion. Since we have already shown that neither CD40L nor 
B cells are necessary to observe deletion, it seemed more 
likely that MMTV was not replicating in mice defective for 
expression of CD40L. 
CD4OL Is Essential for Propagation of the MMTV 
Virus In Vivo 
To determine whether MMTV was replicating in mice that 
lack CD40L, we examined viral integration by polymerase 
chain reaction (PCR) of spleen DNA from male H2bxk mice 
expressing CD40L or not and exposed to MMTV-infected 
milk. A unique restriction site on MMTV (C3H) can be re- 
vealed by cutting with the enzyme Munl (Beutner et al., 
1994), allowing us to discriminate exogenous and endoge- 
nous LTRs expressed in splenic DNA. We used a sensitive 
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Figure 3. The Failure of T Cells to Express CD4OL Prevents Deletion 
of Cognate T Cells in MMTV-Exposed Animals 
CD40L knockout (H-29 females were bred to BiO.BR/J (H-2’) normal 
males. Fl (H-2”‘) mice were foster fed by MMTV or MMTV’ C3HI 
HeN females. V614 plus CD4+ T cells were monitored in PBL of (A), 
Fl males (CWOL knockout) and (B), Fl females (CD4OL+‘-). MMTV 
exposed mice are shown in open symbols, mice not exposed to MMTV 
in closed symbols. Each curve represents an individual animal. Dele- 
tion of T cells in CD40L+‘- mice is MMTV (C3H) SAG specific: expres- 
sion of V56 by PBL CD4’ T cells from mice shown in (A) and (B) at 
the age of 12 weeks was 6.7% f 0.5% and 6.5% for exposed and 
nonexposed males and 9.2% f 0.6% and 7.6% * 0.5% for exposed 
and nonexposed females, respectively. 
assay of probing with an LTR probe on filters to which 
the PCR product was transferred either before or after 
digestion with Munl (Figure 4). Only MMTV-specific frag- 
ment (600 bp, top band) is digested by Mun I into smaller 
fragments, the bigger of which is revealed by hybridiza- 
tion. The nature of intermediate band also amplified in 
infected animals is unknown. This analysis revealed that 
substantial amount of MMTV proviruscould be found in the 
spleens of CD40L-sufficient mice, but not in the spleens 
of uninfected animals, and could be barely detected in 
CD4OLdefective mice (Figure 4, lanes 4 and 6) and only 
after 3 day exposure of the X-ray film. Consistent with 
the hybridization data, mice without CD40L, exposed to 
infectious milk, show no deletion of Vf314+ CD4+ PBL. 
Moreover, MMTV-exposed CD40L- females do not 
transmit the virus (or transmit extremely low amounts) to 
their progeny. When the progeny of such females was 
analyzed at the age of 9 weeks, the percent of VB14+ CD4+ 
PBL was 0.4% f 0.9% (n = 7) while the progeny of 
CD40L+ females had only 5.3% f 1.5% Vf314+CD4+ (n = 
5). Control MMTV- mice contained 9.0% f 0.7 % of VP1 4+ 
CD4+ PBL (n = 3). 
Thus, three pieces of data strongly implicate CD40L in 
the propagation of MMTV in vivo. First, there is no deletion 
of VBlCbearing T cells in these mice. Second, there is 
only barely detectable viral integration in splenic DNA. And 
third, CD40L-deficient mice apparently do not transmit the 
MMTV to their progeny. 
Role for Direct Contact of T Cells with CD40L with 
B Cells Expressing CD40 in Propagation of MMTV 
The data leave one possible caveat with regard to the role 
of T-dependent B cell activation mediated by CD40L. That 
is, we have not formally shown that the Tcells can respond 
to SAG without expressing CD40L. To examine this, we 
took advantage of insect cell membranes containing 
CD40L (Kehry and Castle, 1994). When T cells from nor- 
mal or CD40Ldefective mice are used as responders in 
mixed lymphocyte culture, it can be seen that T cells from 
CD40L knockout mice give a very low response to HYB- 
PRO B cells compared with T cells from normal animals 
(Figure 5A). However, 48 hr of culture of HYB-PRO B cells 
with insect cell membranes expressing CD40L induces 
strong responses from all T cells, whether they express 
CD4OL or not (Figure 58) and it is accompanied by strong 
induction of 87-2 (Figure 5C), which is the relevant costim- 
ulator. To prove that the observed activation was due to 
T cell-independent activation of costimulatory activity, we 
showed that T cell response could be efficiently blocked 
by CTLA-419 (Linsley et al., 1991) (Figure 5D), a ligand for 
87-1, 87-2, and possibly other costimulatory molecules. 
Thus, T cells without CD40L can respond, provided the 
B cells are preactivated. 
Discussion 
In the present experiments, we have shown that CD40L- 
deficient mice and B cell-deficient mice can drive deletion 
of Vf314-bearing T cells, provided the MMTV (C3H) SAG is 
expressed by an endogenous virus. What CD4OL-deficient 
mice cannot do is allow the propagation of the virus ac- 
quired through milk. Thus, the CD40L-CD40 interaction 
plays a key role in viral life cycle. 
Milk laden with virus is ingested, and infects some cell 
type that bears MHC class II on its surface. Possibilities 
include M cells, gut epithelial cells (Kaiserlian et al., 1993) 
Langerhans cells, dendritic cells, macrophages, and B 
cells. It is a consensus view that SAG-dependent T cell 
activation is a key event in the MMTV life cycle (Golovkina 
et al, 1992; Held et al., 1994a). The results with uMT mice 
rule out the B cell as the exceptional cell for initiating the 
T cell response (see Figure 28). A possibility that can not 
be excluded is that initial activation of T cells may be pro- 
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Table 3. No Deletion of V814+CD4+T Cells Can Be Seen in CD4OLDeficient Males Foster-Fed by MMTV-Infected C3HIHeN Females 
MHC of Experiment Percent of V814+. 
foster-fed mice number MMTW CD4OL CD4’T ceIIsb n 
bxk 1 + 6.55 (8.1; 9.0) 2 
bxk 1 + + 6.0 f 0.7 3 
bxk 1 + 9.0 f 0.6 4 
bxk 2 + 8.8 f 0.4 3 
bxk 2 8.1 f 0.5 4 
bxk 2 + + 5.4 f 0.3 3 
bxk 2 + - 8.25 (8.9; 6.6) 2 
k 2 + 7.55 f 0.4 4 
k 2 7.3 1 
k 2 + + 4.6 (4.4; 4.8) 2 
k 2 + 7.55 (7.3; 7.8) 2 
’ Mice were fostered by MMTV+W- C3HIHeN females. 
b Percent of V814+CD4+PBL f SEM, where applicable. Data is shown for 1 O-week-old animals. H-2”k mice were either Fl (B6CD40LKO x BlO.BR) 
or their F2. H-2* MMTVCD4OL’ mice were age-matched BiO.BR. 
n, number of animals per group. 
vided by cells that express SAG but have not integrated 
MMTV. For example, gut epithelial cells have been shown 
to express viral proteins, but no viral DNA (Karapetian et 
al., 1994). It has also not been disproved that virions con- 
tain SAG polypeptides. An important finding that inhibition 
of reverse transcriptase by 3’~azido+deoxythymidine 
(AZT) given to mice prior to injection of MMTV particles 
(Held et al., 1994b) abrogated proliferative reaction of T 
and B cells in the regional lymph nodes does not exclude 
the possibility that initial stimulation of CD40L expression 
by Tcellswascaused by Bcellsoranother celltype without 
integration of theviral genome. It does argue, though, that 
involvement of B cells in the proliferative reaction is rapid 
(within 24-48 hr after injection) and requires reverse tran- 
scription. 
In normal mice naturally exposed to MMTV, the initiating 
12 34 5 6 78 9 to 
< 
:./ 4 
-ii- TTTT 
CD4oL + - + - + 
W814+cD4+ 93 8.5 37 g7 41) 
Figure 4. CD40L-Deficient Mice Show Low Integration of MMlV in 
Splenic DNA 
MMTV-specific PCR products were amplified from equal amount of 
DNA from the spleens of H-2*“D male mice born from CD4OL+‘- H-2W 
females and normal C3HIHeN mates and fostered on MMTV (a) or 
MMTV’ milk (b-e). Animals b and d were CD4OL negative. Amplified 
fragmentsweredigestedwith Munl(lanes2,4,8,8,lO)ormock-treated 
(lanes 1, 3, 5, 7, Q), gel separated, transferred to nylon membrane, 
and hybridized to LTR probe. MMTV (CIH)-specific products are indi- 
cated by arrowheads. PCR product apparently amplified from an en- 
dogenous viral gene and having the same size as uncut exogenous 
MMTV product (600 bp) is marked by arrow. Percent of VplC CD4+ 
PBL is shown for each mouse at the age of 9 weeks. 
cell (B or non-B) stimulates T cells, which in turn express 
CD40L and activate infected B cells, driving replication of 
the virus. There may be a few B cells infected, which is 
insufficient to promote the spread of the virus without am- 
plification by several cycles of T-B interactions, depen- 
dent on CD40L-CD40 interactions. This interaction in- 
duces 87-2 on the B cell, further expanding the T cell pool 
reactive to SAG, which in its turn stimulates further the B 
cell proliferation and MMTV propagation. It has been 
shown in experiment8 with footpad injections of MMlV 
into adult animals that the majority of proliferating B cell8 
express surface immunoglobulin G (IgG), suggesting that 
preactivated B cells were the primary targets of infection 
(Held et al., 1994b). We would like to suggest that the IgG 
expression results from activation of the CD40L-CD40 
pathway, which triggers the isotype switch (Hodgkin et al., 
1990; Noelle et al., 1990; Gascan et al., 1991; Aruffo et 
al., 1993). An important difference between adult and new- 
born animals is in the absence of preactivated B cells in 
the latter, so that it is hard to draw parallels in the two 
experimental systems. 
Why the activation process ceases, with apoptosis of 
the responding T cells, is a mystery not yet solved. Suffice 
it to say that the mechanism of activation by SAG, as op- 
posed to activation by peptide antigen, is probably quite 
different (Liu et al., 1991; Weber and Cantor, 1994). Nota- 
bly, deletion of cognate T cells is a slow process, which 
can be detected in the periphery starting at fourth week 
postpartum (Marrack et al., 1991). Both CD4 and CD8 
cells are being deleted, implicating the participation of the 
thymus in this process (Ignatowicz et al., 1992). There 
may be other sites in the organism that control the deletion 
process, including gut (Webb and Sprent, 1993). From our 
data and the data by Beutner et al., (1994) with PMT mice, 
it is obvious that non-B cells may mediate deletion in the 
periphery as well as in the thymus. 
There are further interesting consequences of this 
model. The deletion is a progressive process, suggesting 
that it may be of importance to MMTV, rather than being 
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an uncontrolled devastation of cells that have fulfilled their 
function, Since SAG-reactive T cells are able to activate 
the costimulatory function of SAG-expressing cells, they 
may participate in an antiviral immune response. Resting 
B cells have been shown to be tolerogens rather than stim- 
ulators for naive T cells (Eynon and Parker, 1992; Fuchs 
and Matzinger, 1992). To activate antiviral immunity they 
might need to express costimulatory molecules, which 
may be achieved by SAG-TCR plus CD40L-CD40 interac- 
tion with cognate T cells. Unlike the activation of T cells 
by SAG, their deletion does not require the expression of 
costimulatory molecules (Jones et al., 1993) and, hence, 
may be easily achieved by SAG presented by various cell 
types. The virus may use the ability to delete the re- 
sponding T cells to maintain itself in the host organism 
until the mammary gland is infected and transmission to 
the offspring is inevitable. 
Finally, which cell is used as a vehicle to bring MMTV 
to the mammary gland is not clear. It has been shown that 
infection in adult animal is multidirectional (Held et al., 
1994a) and may be propagated by B cells or CD4 and 
CD8 subsets of T cells (Waanders et al., 1993). 
Experimental Procedures 
Mice 
CD40L-deficient mice were described (Xu et al., 1994). The strain has 
been continuously bred to C57BU6J (66). BlO.BR/J were purchased 
from Jackson Labs (Bar Harbor, Maine). C3HIHeIN both MTV+ and 
MN were from National Institutes of Health (Frederick, Maryland). 
MMTV transgenic mice (HYB-PRO and MTV ORFI 9) were a gift from 
Dr. S. Ft. Ross (University of Pennsylvania, Philadelphia, Pennsylva- 
nia). uMT mice were a gift from Dr. K. Rajewsky(Universityof Cologne, 
Cologne, Federal Republic of Germany). 
Flow Cytometery 
PBL or spleen cells were stained and analyzed as described (Golov- 
kina et al.. 1992). MAbs against mouse CD4 and CD6 molecules di- 
Figure 5. Activation of Costimulatory Mole 
cules on Stimulator Cells Turns Low- 
Responder CD4OL Knockout T Cells into High 
Responders to HYB-PRO 
Comparison of the proliferative responses 
(measured by PHjthymidine incorporation) of 
lymph node cells from normal and CD4OL 
knockout animals to (A) splenic B cells or (B) 
CWOL-activated B cells from HYB-PRO 
transgenic mice. Stimulation by splenic B cells 
and activated B cells from nontransgenic ani- 
mals treated in the same manner served as a 
negative control in this experiment and non- 
SAG-specific PHjthymidine uptake was sub 
tracted from the data shown. 
(C) Expression of 87-2 by 6220’ cells from 
HYB-PRO mice, stained before (I, 2) and after 
(3, 4) stimulation with insect cell membranes, 
expressing CD4OL. Peaks 1 and 3, control 
staining; 2 and 4, staining with anti-B7-2 MAb. 
(D) CTLA4lg (common ligand for 87-l and 
87-2 costimulatory molecules) blocks prolifera- 
tive response of CD4OL knockout lymph node 
cells against CD4OL-activated B cells. Final 
concentrations of CTLA4lg were 10, 3, and 1 
&ml; final concentrations of control immuno- 
globulin, 10 @ml. 
rectly conjugated to R-phycoerythrin or RED613 were from GIBCO 
BRL (Grand Island, New York). Anti-V6-specific MAbs (antiV66, Kana- 
gawa, 1969; and antiV614, Liaoet al., 1969)conjugated tofluorescein 
isothiocyanate as well as biotinylated anti-67-2 (Hathcock et al., 1993) 
were from PharMingen (San-Diego, California). Biotinyfated antibodies 
were followed by streptavidin-fluorescein isothtiocyanate conjugate 
(Caltag Laboratories, San Francisco, California). 
In Vltro Cell Actlvatlon Asseys 
T cells were activated by cocultivation of 3 x 1 (r lymph node cells with 
5 x 105 irradiated (2000 rada) or mitomycin c (Boehringer Mannheim 
GmBH, Mannheim, Federal RepublicofGermany) treatedsplenocytes 
(30 min at 37OC, 50 pg/ml of mitomycin c). Proliferation of responding 
cells was quantified by PH]thymidine incorporation. The reactivity of 
a T cell hybrkfoma Kox15-6.3 (Kappler et al., 1966) was tested by 
cocultivation of 5 x l(r hybridoma cells with variable numbers of 
stimulator cells for 16 hr. Supernatants were tested for IL-2 production 
by CTLL IL-2-dependent cell line proliferation. All assays were done 
in duplicate or triplicate cultures in 96-well flat-bottomed plates (Bec- 
ton-Dickinson, Lincoln Park, New Jersy) in complete Click’s EHAA 
medium with 5% fetal calf serum as described (Golovkina et al., 1992). 
B Cell Acilvetlon 
Spleen cells were depleted of T cells by treatment with MAbs against 
Thyl.2 (Marshak-Rothstein et al., 1979) CD4 (Dialynas et al., 1963) 
and CD6 (Ledbetter and Herzenberg, 1979) followed by rabbit comple- 
ment (Cederlane Laboratories, Limited, Horby, Ontario, Canada) and 
dead cells removal by density gradient centrifugation. Cells (IO? were 
then cultured for 46 hr at 37OC in the presence of a 1% preparation 
of insect cell membranes (Kehry and Castle, 1994), expressing gp39 
(CD4OL) protein in Click’s EHAA medium supplemented with 5% fetal 
calf serum. Cells were treated with mitomycin C, extensively washed, 
and used as stimulators in a T cell activation assay. Cells from non- 
transgenic C3HIHeIN treated exactly the same way were used as nega- 
tive control and the values of resulting nonspecific 13H]thymidine up 
take were subtracted from the data. Samples of activated cells were 
stained with anti-B220 (Coffman, 1963) conjugated to phycoerythrin 
(PharMingen) (more than 90% positive) and biotinylated anti-87-2. 
Purified CTlA4lg chimeric protein (Linsley et al., 1991) used to block 
the anti-HYB-PRO response was a gift from Dr. P. S. Linsley (Bristol- 
Myers Sqiubb Company, Seattle, Washington). 
In Vlvo T Cell Actlvatlon 
Mice were injected in the footpads with 30 ng of Ea52-66 peptide in 
7:54OL-CD40 Interaction in MMTV Infection 
CFA (DIFCO Laboratories, Detroit, Michigan). Peptide was synthe- 
sized by Yale University W. M. Keck Biotechnology Resource Center. 
Regional lymph nodes were removed at day 8 after immunization. 
Proliferative responses of 4 x 105 lymph node cells per well of 98well 
plates were tested in triplicate after stimulation for 48 hr with either 
antigenic peptide, irrelevant peptide derived from invariant chain (no 
response was detected in all cases), or tuberculin preparation. 
Detection of MMTV Provirus 
DNA was extracted from spleens of g-week-old mice exposed to in- 
fected and noninfected milk. PCR conditions and primers were exactly 
as described (Beutner et al., 1994). Amplified products were cut with 
Munl (GIBCO BRL) restriction enzyme to distinguish exogenous and 
endogenous viral LTR and run over 1.2% agarose gel. transferred to 
nylon membranes (Zeta-Probe, GT, Bio-Rad Labotratories, Richmond, 
California), and hybridized to “P-labeled LTR probe (Golovkina et 
al.,1992), a gift from Dr. T. Golovkina (University of Pennsylvania), 
according to Southern (1975). 
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